Delivery Order SPE2DR25D9103-SPE2DR26FBYLS

The Defense Logistics Agency awarded a delivery order valued at $2,518.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award was issued without any identified subcontractor relationships.

This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, has a ceiling value of $499,999,999 and extends through December 31, 2036, with a structure consisting of a 30-month base period and three 30-month option periods. Through this vehicle, DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors positioned to fulfill the diverse pharmaceutical and medical supply requirements of the military medical system.